INFLUENCE OF APOE ε4 ON CSF BIOMARKERS OF THE NEUROVASCULAR UNIT DURING MILD DEMENTIA AND ALZHEIMER'S DISEASE

被引：0
|
作者：
Sweeney, M. D. [1 ]
Sagare, A. P. [1 ]
Nation, D. A. [2 ]
Halliday, M. R. [1 ]
Fagan, A. M. [3 ]
Morris, J. C. [4 ]
Zlokovic, B. V. [1 ]
机构：
[1] Univ Southern Calif, Keck Sch Med, Dept Physiol & Biophys, Zilkha Neurogenet Insitute, Los Angeles, CA USA
[2] Univ Southern Calif, Dept Psychol, Los Angeles, CA USA
[3] Washington Univ, Sch Med, Dept Neurol, Hope Ctr Neurodegenerat Disorders,Knight Alzheime, St Louis, MO 63130 USA
[4] Washington Univ, Sch Med, Dept Neurol, Hope Ctr Neurodegenerat Disorders, St Louis, MO 63130 USA
来源：
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM | 2016年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
911
引用
收藏
页码：731 / 732
页数：2
相关论文
共 50 条
  • [1] Influence of APOE ε4 on performance of CSF biomarkers in differentiating clinical Alzheimer's disease
    Wang, Yan
    Li, Fangyu
    Qin, Qi
    Li, Tingting
    Wang, Qi
    Li, Yan
    Li, Ying
    Jia, Jianping
    JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE, 2025, 12 (04):
  • [2] Cerebrospinal fluid biomarkers of neurovascular dysfunction in mild dementia and Alzheimer's disease
    Sweeney, Melanie D.
    Sagare, Abhay P.
    Zlokovic, Berislav V.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2015, 35 (07): : 1055 - 1068
  • [3] Influence of APOE Genotype on Alzheimer's Disease CSF Biomarkers in a Spanish Population
    Monge-Argiles, J. A.
    Gasparini-Berenguer, R.
    Gutierrez-Agullo, M.
    Munoz-Ruiz, C.
    Sanchez-Paya, J.
    Leiva-Santana, C.
    BIOMED RESEARCH INTERNATIONAL, 2016, 2016
  • [4] CSF biomarkers for Alzheimer’s pathology and the effect size of APOE ɛ4
    U Andreasson
    R Lautner
    J M Schott
    N Mattsson
    O Hansson
    S-K Herukka
    S Helisalmi
    M Ewers
    H Hampel
    A Wallin
    L Minthon
    J Hardy
    K Blennow
    H Zetterberg
    Molecular Psychiatry, 2014, 19 : 148 - 149
  • [5] CSF biomarkers for Alzheimer's pathology and the effect size of APOE ε4
    Andreasson, U.
    Lautner, R.
    Schott, J. M.
    Mattsson, N.
    Hansson, O.
    Herukka, S-K
    Helisalmi, S.
    Ewers, M.
    Hampel, H.
    Wallin, A.
    Minthon, L.
    Hardy, J.
    Blennow, K.
    Zetterberg, H.
    MOLECULAR PSYCHIATRY, 2014, 19 (02) : 148 - 149
  • [6] No association of CSF biomarkers with APOEε4, plaque and tangle burden in definite Alzheimer's disease
    Engelborghs, Sebastiaan
    Sleegers, Kristel
    Cras, Patrick
    Brouwers, Nathalie
    Serneels, Sally
    De Leenheir, Evelyn
    Martin, Jean-Jacques
    Vanmechelen, Eugeen
    Van Broeckhoven, Christine
    De Deyn, Peter Paul
    BRAIN, 2007, 130 : 2320 - 2326
  • [7] Vascular biomarkers and ApoE4 expression in mild cognitive impairment and Alzheimer's disease
    Oviedo, Diana C.
    Lezcano, Hector
    Perez, Ambar R.
    Villarreal, Alcibiades E.
    Carreira, Maria B.
    Isaza, Baltasar
    Wesley, Lavinia
    Grajales, Shantal A.
    Fernandez, Sara
    Frank, Ana
    Britton, Gabrielle B.
    AIMS NEUROSCIENCE, 2018, 5 (02) : 148 - 161
  • [8] Joint Effect of Hypertension and APOE Genotype on CSF Biomarkers for Alzheimer's Disease
    Kester, Maartje I.
    van der Flier, Wiesje M.
    Mandic, Gorana
    Blankenstein, Marinus A.
    Scheltens, Philip
    Muller, Majon
    JOURNAL OF ALZHEIMERS DISEASE, 2010, 20 (04) : 1083 - 1090
  • [9] The Effects of CSF Neurogranin and APOE ε4 on Cognition and Neuropathology in Mild Cognitive Impairment and Alzheimer's Disease
    Fan, Yulan
    Gao, Ying
    Therriault, Joseph
    Luo, Jing
    Ba, Maowen
    Zhang, Hua
    FRONTIERS IN AGING NEUROSCIENCE, 2021, 13
  • [10] The neurovascular unit in Alzheimer's disease
    Taylor, S. L.
    Petzold, G.
    GLIA, 2019, 67 : E192 - E193
12345